Simulating large systems with Regression Language Models
Generative AI
-
-
Shah Muhammad, Sweco: How AI is building the future of our cities
Shah Muhammad, who leads AI Innovation at the design and engineering firm Sweco, offers his insights into how AI is building the cities of the future. Ever been stuck in traffic and thought, “Surely, there’s a better way to design this city?” Or walked past a giant new building and wondered if it would be…
-
AI visionaries converge in Shanghai to chart the future of innovation
A news report from english.shanghai.gov.cn Industry leaders in artificial intelligence gathered for a roundtable discussion on July 27, during the World Artificial Intelligence Conference (WAIC), focusing on China’s pivotal role in shaping the global AI landscape. Hosted by the Foreign Affairs Office of the Shanghai Municipal People’s Government and organized by China Daily, the event, themed “Intelligent Dialogues,…
-
Everads Shares Clinical Trial Results at ASRS 2025 Meeting
– Clinical study confirms safety, feasibility, and tolerability of the Everads Injector– – Preclinical data demonstrate the feasibility of in-office, minimally invasive suprachoroidal buckling using the Everads Injector to repair retinal detachments – Everads Therapy, a clinical-stage company leveraging its novel suprachoroidal delivery technology to advance the treatment of retinal diseases, today announced two oral presentations…
-
ARCHIMED Acquires Arkstone to Boost AI Clinical Decision Market
Arkstone, an innovative biotechnology company democratizing infectious disease expertise and fighting antimicrobial resistance, has been acquired by global healthcare private equity firm ARCHIMED, which now holds a majority stake. Arkstone, a pioneer in machine learning (ML) and artificial intelligence (AI)-driven infectious disease clinical decision support and antimicrobial stewardship, has announced being acquired by ARCHIMED, a…
-
BARDA awards $10M to RIVANNA to fast-track CADe/x AI module
RIVANNA®, developers of imaging-based medical technologies, announced that it received $9.92 million in federal funding of a contractual option from the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response (ASPR) within the U.S. Department of Health and Human Services (HHS). With the execution, this option funding will support the…
-
Health Gorilla Joins CMS Network Enabling AI-Ready Data Exchange
Health Gorilla, a designated Qualified Health Information Network (QHIN) under the Trusted Exchange Framework and Common Agreement (TEFCA), today announced its participation as one of the inaugural data network early adopters in the CMS-Aligned Network. Recognized by the Centers for Medicare & Medicaid Services (CMS) as a trusted exchange partner, Health Gorilla brings a unique…
-
FuturHealth to Deliver Affordable, FDA-Approved GLP-1s Nationwide
As restrictions tighten on compounded semaglutide, FuturHealth now offers name-brand GLP-1s—like Wegovy®— through Novo’s cash-pay program FuturHealth, a leading provider of personalized weight-loss solutions, today announced it is giving its members seamless access to FDA-approved GLP-1 medications – including Wegovy® – at highly affordable, cash-pay prices, delivered directly to their doors. This service is enabled by the…
-
OSR Holdings Updates on Woori IO AI-Driven Glucose Tech Deal
OSR Holdings, Inc. (NASDAQ: OSRH), a global healthcare company advancing biomedical and wellness innovation, today issued a strategic update regarding its recently announced Term Sheet with Woori IO Co., Ltd. (“WORIO”), a South Korean medical device company pioneering noninvasive glucose monitoring technology. The transaction, once completed, will result in WORIO becoming a wholly owned subsidiary of…
-
Ultromics Raises $55M to Scale AI Heart Failure Detection
AI heart failure diagnostics innovator makes it possible to catch deadly heart failure earlier by analyzing the most common heart scan in the world and proactively alerting clinicians FDA-cleared, reimbursed by Medicare, and live in top U.S. hospitals, Ultromics is now scaling nationwide to make early heart failure detection part of routine cardiac care, wherever…
